Q32 Bio Valuation
| QTTB Stock | 3.87 0.15 3.73% |
At this time, the entity appears to be undervalued. Q32 Bio owns a latest Real Value of USD6.42 per share. The recent price of the entity is USD3.87. Our model determines the value of Q32 Bio from reviewing the entity fundamentals such as price to book of 3.55 X, and Return On Asset of -0.33 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Q32 Bio's valuation include:
Undervalued
Today
Please note that Q32 Bio's price fluctuation is very risky at this time. Calculation of the real value of Q32 Bio is based on 3 months time horizon. Increasing Q32 Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Q32 Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Q32 Stock. However, Q32 Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.87 | Real 6.42 | Target 15.0 | Hype 3.93 | Naive 3.44 |
The real value of Q32 Stock, also known as its intrinsic value, is the underlying worth of Q32 Bio Company, which is reflected in its stock price. It is based on Q32 Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Q32 Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Q32 Bio helps investors to forecast how Q32 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Q32 Bio more accurately as focusing exclusively on Q32 Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Q32 Bio's intrinsic value based on its ongoing forecasts of Q32 Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Q32 Bio's closest peers. If more than one evaluation category is relevant for Q32 Bio we suggest using both methods to arrive at a better estimate.
Q32 Bio Cash |
|
Q32 Bio Total Value Analysis
Q32 Bio is at this time anticipated to have valuation of 16.96 M with market capitalization of 49.46 M, debt of 18.9 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Q32 Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
16.96 M | 49.46 M | 18.9 M |
Q32 Bio Asset Utilization
One of the ways to look at asset utilization of Q32 is to check how much profit was generated for every dollar of assets it reports. Q32 Bio owns a negative utilization of current and long term assets of -0.33 %, losing USD0.00335 for each dollar of current and long term assets held by the entity. Inadequate asset utilization implies the company is being less competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of Q32 Bio shows how discouraging it operates for each dollar spent on its current and long term assets.Q32 Bio Profitability Analysis
Considering Q32 Bio's profitability and operating efficiency indicators, Q32 Bio's profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess Q32 Bio's ability to earn profits and add value for shareholders.Net Loss | First Reported 2017-09-30 | Previous Quarter -9.5 M | Current Value -7.4 M | Quarterly Volatility 22.3 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.65 |
|
|
For Q32 Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Q32 Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Q32 Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Q32 Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Q32 Bio over time as well as its relative position and ranking within its peers.
Q32 Bio Earnings per Share Projection vs Actual
The next projected EPS of Q32 Bio is estimated to be -0.68875 with future projections ranging from a low of -0.8375 to a high of -0.54. Q32 Bio's most recent 12-month trailing earnings per share (EPS TTM) is at -3.22. Please be aware that the consensus of earnings estimates for Q32 Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Q32 Bio Earnings Estimation Breakdown
The calculation of Q32 Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Q32 Bio is estimated to be -0.68875 with the future projection ranging from a low of -0.8375 to a high of -0.54. Please be aware that this consensus of annual earnings estimates for Q32 Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.84 Lowest | Expected EPS | -0.54 Highest |
Q32 Bio Earnings Projection Consensus
Suppose the current estimates of Q32 Bio's value are higher than the current market price of the Q32 Bio stock. In this case, investors may conclude that Q32 Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Q32 Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 2 | 55.29% | -0.6 | -0.68875 | -3.22 |
Q32 Bio Ownership Allocation
The market capitalization of Q32 Bio is USD49.46 Million. Over half of Q32 Bio's outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company.Q32 Bio Profitability Analysis
Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (26.39 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Q32 Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Q32 Bio and how it compares across the competition.
About Q32 Bio Valuation
The stock valuation mechanism determines Q32 Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Q32 Bio. We calculate exposure to Q32 Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Q32 Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -560 K | -532 K | |
| Pretax Profit Margin | 7.23 | 7.59 | |
| Operating Profit Margin | 6.53 | 6.86 | |
| Net Profit Margin | 7.27 | 7.64 | |
| Gross Profit Margin | 0.65 | 0.58 |
Q32 Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Q32 Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Q32 we look at many different elements of the entity such as Q32's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Q32 Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Q32 Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Q32 Bio's worth.Complementary Tools for Q32 Stock analysis
When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |